EMLA

06/01/2002 - "There were no clinically or statistically significant differences between treatment with ELA-Max and EMLA in parental or blinded researcher Observed Behavioral Distress scores, the most frequent response at any observation time being "no distress." This study demonstrates that a 30-minute application of ELA-Max without occlusion is as safe and as effective for ameliorating pain associated with venipuncture as a 60-minute application of the prescription product EMLA requiring occlusion."
02/01/2011 - "Although most patients experienced limited pain during scaling, a significant reduction of pain is achieved by using EMLA cream and ultrasonic scaler."
01/01/2007 - "EMLA-C can be effective in reducing wrist pain during TRCP without any significant drug-related complications when the application time is 1 to 3 hours before the procedure."
01/01/1994 - "Application of Emla for at least 2 h prior to injection resulted in a significant reduction in the pain of both preparations, but was unable to reduce the pain of rHuEpo alpha to that of rHuEpo beta. "
01/01/1985 - "EMLA relieved pain significantly better than placebo (p less than 0.001), and the procedure was considered to be easier after EMLA treatment. "

07/01/1996 - "EMLA cream (10 g) was applied on the skin over the area (64-100 cm2) where the shock waves were to be focussed. "
10/01/1992 - "Before operation, EMLA or placebo cream was applied to the patient's back at the anticipated shock head-skin interface. "
10/01/1996 - "This randomized, double blind, placebo controlled study evaluated the efficacy of EMLA cream during extracorporeal shock wave lithotripsy (ESWL) using the Dornier MFL 5000 lithotripter. "
07/01/1996 - "EMLA cream for renal extracorporeal shock wave lithotripsy in ambulatory patients."
10/01/1996 - "Also, VAS for maximal pain, average pain and satisfaction and the total number of shock waves were similar although the EMLA group received more shock waves at the lower energy level (kV) (P < 0.0001). "

06/01/1993 - "No statistically significant differences in local reactions or adverse effects on granulation tissue, ulcer area or bacterial flora were observed in the EMLA-treated patients compared with the control patients."
01/01/2003 - "Research is required to determine the impact of debridement and of EMLA on ulcer healing. "
10/01/2001 - "The analgesic efficacy of EMLA for the relief of chronic ulcer pain deserves further study."
09/01/2003 - "In 12 patients (1.1%) a burning sensation was reported directly after the application of EMLA cream to the ulcer, which, however, subsided within 15-20 min. In our experience, sharp debridement in percutaneous analgesia with EMLA is efficient, economical, safe, and tolerable for the patient."
03/01/2001 - "Four double-blind studies and one open randomised controlled study show that EMLA applied to the ulcer for 30-45 min under occlusion significantly reduces the pain from sharp debridement, decreases the incidence of post-debridement pain and reduces the time needed to achieve a clean ulcer, giving potential savings in healthcare costs. "

01/01/1990 - "The analgesic effect of EMLA 5% cream for surgical cleansing of leg ulcers was investigated in an open study and in a double-blind comparison with placebo. "
07/01/2012 - "Eutectic mixture of local anaesthetics (EMLA) 5% cream as a primary dressing on a painful lower leg ulcer."
10/01/2001 - "A single 24-h application of 5-10 g (median 6.75) of EMLA was given to 10 patients with painful leg ulcers measuring 50-100 cm2. "
09/01/1999 - "[Use of EMLA Creme in leg ulcers: usefulness and limits]."
05/01/1999 - "EMLA cream for the débridement of venous leg ulcers."

09/01/1997 - "We evaluated the analgesic efficacy of EMLA cream after repeated bone marrow aspirations or lumbar punctures (LPs) in children with cancer, and compared the ratings among patients, their parents, physicians, and nurses. "
07/01/1990 - "Potential benefit of the topical anesthetic EMLA prior to lumbar puncture was studied in children with cancer. "
05/01/1994 - "Trial of a topically administered local anesthetic (EMLA cream) for pain relief during central venous port accesses in children with cancer."
07/01/2000 - "The application of EMLA to patients undergoing breast surgery for cancer reduced the postoperative analgesic requirements and the incidence and intensity of chronic pain."
07/01/2000 - "EMLA reduces acute and chronic pain after breast surgery for cancer."